Lumosa Therapeutics Co., Ltd. (6535.TWO)
TWD 160.0
(-9.86%)
TWD 160.0
(-9.86%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.65 Billion TWD | -12.17% |
| 2022 | 1.88 Billion TWD | -19.71% |
| 2021 | 2.34 Billion TWD | 31.63% |
| 2020 | 1.78 Billion TWD | 34.74% |
| 2019 | 1.32 Billion TWD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 1.59 Billion TWD | 5.02% |
| 2024 Q1 | 1.51 Billion TWD | -8.23% |
| 2023 Q4 | 1.65 Billion TWD | -4.47% |
| 2023 Q1 | 2 Billion TWD | 6.48% |
| 2023 FY | 1.65 Billion TWD | -12.17% |
| 2023 Q3 | 1.73 Billion TWD | -6.67% |
| 2023 Q2 | 1.85 Billion TWD | -7.48% |
| 2022 Q3 | 1.78 Billion TWD | 0.0% |
| 2022 Q4 | 1.88 Billion TWD | 5.53% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | 128.04 Million TWD | -1193.493% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 2.9 Billion TWD | 42.904% |
| Level Biotechnology Inc. | 822.67 Million TWD | -101.329% |
| Sagittarius Life Science Corp | 664.72 Million TWD | -149.168% |
| NeoCore Technology Co., Ltd. | 548.74 Million TWD | -201.829% |
| TaiMed Biologics Inc. | 3.89 Billion TWD | 57.465% |
| GlycoNex Incorporation | 1.55 Billion TWD | -6.663% |
| VBI | 452.1 Million TWD | -266.351% |
| GeneReach Biotechnology Corp. | 1.17 Billion TWD | -40.823% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 748.57 Million TWD | -121.259% |
| SynCore Biotechnology Co.,Ltd | 378.36 Million TWD | -337.75% |
| Genomics BioSci & Tech. Co.,Ltd. | 1.13 Billion TWD | -46.076% |
| Visgeneer Inc. | 397.17 Million TWD | -317.014% |
| Mycenax Biotech Inc. | 3.77 Billion TWD | 56.072% |
| Sunmax Biotechnology Co., Ltd. | 2.15 Billion TWD | 23.286% |
| G&E Herbal Biotechnology Co., Ltd. | 883.09 Million TWD | -87.554% |
| Neith Corporation | 192.15 Million TWD | -761.958% |
| Medigen Vaccine Biologics Corporation | 6.09 Billion TWD | 72.815% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 73.55 Million TWD | -2151.664% |
| Enimmune corporation | 604.82 Million TWD | -173.843% |
| TaiRx, Inc. | 833.74 Million TWD | -98.655% |
| CHO Pharma, Inc. | 3.08 Billion TWD | 46.33% |
| EirGenix Inc. | 11.16 Billion TWD | 85.162% |
| BioLASCO Taiwan Co., Ltd. | 573.13 Million TWD | -188.984% |
| Sunny Pharmtech Inc. | 1.71 Billion TWD | 3.275% |
| Lin BioScience, Inc. | 3.59 Billion TWD | 53.95% |
| BioGend Therapeutics Co., Ltd. | 1.05 Billion TWD | -57.669% |
| Feng Chi Biotech Corp. | 301.03 Million TWD | -450.2% |
| Bio Preventive Medicine Corp. | 264.65 Million TWD | -525.821% |
| Lukas Biomedical Inc. | 441.19 Million TWD | -275.411% |
| RBC Bioscience Corporation | 753.79 Million TWD | -119.727% |
| BiOptic Inc. | 613.77 Million TWD | -169.852% |
| BRIM Biotechnology, Inc. | 1.77 Billion TWD | 6.881% |
| Shine-On BioMedical Co.,Ltd. | 1.15 Billion TWD | -42.818% |
| Great Novel Therapeutics Biotech & Medicals | 644.84 Million TWD | -156.848% |
| Syngen Biotech Co.,Ltd. | 3.1 Billion TWD | 46.679% |
| Advagene Biopharma Co., Ltd. | 147.93 Million TWD | -1019.607% |
| NaviFUS Corp. | 490.53 Million TWD | -237.647% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 1.22 Billion TWD | -35.127% |
| Sinew Pharma Inc. | 1.36 Billion TWD | -21.484% |
| Andros Pharmaceuticals Co.,Ltd | 529.14 Million TWD | -213.01% |
| Greenyn Biotechnology Co., Ltd | 1.16 Billion TWD | -42.612% |
| AP Biosciences Inc | 890.75 Million TWD | -85.941% |
| Medigen Biotechnology Corp. | 8.52 Billion TWD | 80.577% |
| 3D Global Biotech Inc. | 324.14 Million TWD | -410.964% |
| Pharmosa Biopharm Inc. | 1.33 Billion TWD | -24.192% |
| Intech Biopharm Corporation | 2.71 Billion TWD | 38.907% |
| Oneness Biotech Co., Ltd. | 15.36 Billion TWD | 89.22% |
| Eusol Biotech Co.,Ltd. | 410.25 Million TWD | -303.716% |
| TWi Biotechnology, Inc. | 396.85 Million TWD | -317.355% |
| Ever Supreme Bio Technology Co., Ltd | 2.07 Billion TWD | 20.215% |
| TCI GENE Inc. | 1.16 Billion TWD | -42.055% |
| MegaPro Biomedical Co., Ltd | 294.58 Million TWD | -462.249% |
| Senhwa Biosciences, Inc. | 1.36 Billion TWD | -21.488% |
| Taiwan Bio Therapeutics Co., Ltd | 941.76 Million TWD | -75.87% |
| NatureWise Biotech & Medicals Corporation | 698.45 Million TWD | -137.136% |
| PharmaEngine, Inc. | 3.95 Billion TWD | 58.11% |
| Savior Lifetec Corporation | 3.82 Billion TWD | 56.672% |
| TaiGen Biopharmaceuticals Holdings Limited | 1.22 Billion TWD | -34.675% |
| OBI Pharma, Inc. | 5.6 Billion TWD | 70.444% |
| Meribank Biotech Co., Ltd | 1.06 Billion TWD | -55.957% |
| Acepodia, Inc. | 6.81 Billion TWD | 75.709% |
| Caliway Biopharmaceuticals Co., Ltd. | 3.82 Billion TWD | 56.716% |